Clinical Trial Update: A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice

View source ↗

Summary

A treatment-effectiveness study evaluating Anifrolumab for systemic lupus erythematosus in routine clinical practice is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Anifrolumab (anifrolumab)

Snippet

Sponsor: AstraZeneca | Conditions: Systemic Lupus Erythematosus | Status: ACTIVE_NOT_RECRUITING